Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 May 16;23(1):494.
doi: 10.1186/s12913-023-09477-6.

Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

Alexandra N Lea  1 , Tory M Levine  2 , Thibaut Davy-Mendez  3 , Amy Leibowitz  2 , Andrea Altschuler  2 , Jason Flamm  4 , C Bradley Hare  5 , Mitchell N Luu  6 , Michael J Silverberg  2 , Derek D Satre  2   7
Affiliations
Clinical Trial

Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

Alexandra N Lea et al. BMC Health Serv Res. .

Abstract

Background: Mental health and substance use disorders disproportionately affect people with HIV (PWH), and may have been exacerbated during COVID-19. The Promoting Access to Care Engagement (PACE) trial was designed to assess the effectiveness of electronic screening for mental health and substance use in HIV primary care and enrolled PWH from October 2018 to July 2020. Our objective here was to compare screening rates and results for PWH before (October 2018 - February 2020) and early in the COVID-19 pandemic (March-July 2020).

Methods: Adult (≥ 18 years) PWH from 3 large HIV primary care clinics in a US-based integrated healthcare system were offered electronic screening online or via in-clinic tablet computer every 6 months. Screening completion and results (for depression, suicidal ideation, anxiety, and substance use) were analyzed using logistic regression with generalized estimating equations to estimate prevalence ratios (PR) before and after the start of the regional COVID-19 shelter-in-place orders on March 17, 2020. Models adjusted for demographics (age, sex, race/ethnicity), HIV risk factors (men who have sex with men, injection drug use, heterosexual, other), medical center, and modality of screening completion (online or tablet). We conducted qualitative interviews with providers participating in the intervention to evaluate how the pandemic impacted patient care.

Results: Of 8,954 eligible visits, 3,904 completed screenings (420 during COVID, 3,484 pre-COVID), with lower overall completion rates during COVID (38% vs. 44%). Patients completing screening during COVID were more likely to be White (63% vs. 55%), male (94% vs. 90%), and MSM (80% vs., 75%). Adjusted PRs comparing COVID and pre-COVID (reference) were 0.70 (95% CI), 0.92 (95% CI), and 0.54 (95% CI) for tobacco use, any substance use, and suicidal ideation, respectively. No significant differences were found by era for depression, anxiety, alcohol, or cannabis use. These results were in contrast to provider-reported impressions of increases in substance use and mental health symptoms.

Conclusion: Findings suggest PWH had modest declines in screening rates early in the COVID-19 pandemic which may have been affected by the shift to telemedicine. There was no evidence that mental health problems and substance use increased for PWH in primary care.

Trial registration: NCT03217058 (First registration date: 7/13/2017); https://clinicaltrials.gov/ct2/show/NCT03217058.

Keywords: COVID-19; HIV; Mental Health; Screening; Substance use.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Unadjusted Screening Results Before COVID vs. During Early COVID
See this image and copyright information in PMC

References

    1. Koenig LJ, Khurana N, Islam MH, Gopalappa C, Farnham PG. Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the United States. AIDS. 2023. Mar 6. Epub ahead of print. - PMC - PubMed
    1. Bershteyn A, Richard E, Zhou Q, Khan MR, Scheidell JD, Manandhar-Sasaki P, et al. Potential health benefits of integrated screening strategies for alcohol, tobacco, other substance use, depression, anxiety, and chronic pain among people living with HIV in the USA: a mathematical modelling study. Lancet HIV. 2023;10(2):e118–e25. doi: 10.1016/S2352-3018(22)00361-7. - DOI - PubMed
    1. DeLorenze GN, Satre DD, Quesenberry CP, Tsai AL, Weisner CM. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS. 2010;24(11):705–12. doi: 10.1089/apc.2010.0139. - DOI - PMC - PubMed
    1. Chichetto NE, Kundu S, Freiberg MS, Butt AA, Crystal S, So-Armah KA, et al. Association of Syndemic Unhealthy Alcohol Use, cigarette use, and Depression with all-cause mortality among adults living with and without HIV infection: Veterans Aging Cohort Study. Open Forum Infect Dis. 2019;6(6):ofz188. doi: 10.1093/ofid/ofz188. - DOI - PMC - PubMed
    1. Zaami S, Marinelli E, Varì MR. New Trends of substance abuse during COVID-19 pandemic: an International Perspective. Front Psychiatry. 2020;11:700. doi: 10.3389/fpsyt.2020.00700. - DOI - PMC - PubMed

Publication types

Associated data